Recall Record

Glens Falls, NY, United States

Angiodynamics Inc. (Navilyst Medical Inc.) recalls

9 recalls recorded since 2018, most recently on 22 February 2021. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)0
Terminated or completed9
Class I (FDA)0

Terminated Class II Medical devices

Recall started
22 February 2021
Terminated
19 July 2022
Reason
AngioDynamics, Inc. is recalling a specific batch of AngioDynamics Implantable Infusion Port kits and Valved introducers that may have potential for compromised sterility of the device. Only the specific product/lot of the kit identified below is affected by this recall action. The Product Description, Product Number, Ref./Catalog Number and Batch/Lot number is provided below. No other products are affected by this recall.
Distribution
US Nationwide distribution in the states of AR, CA, CO, FL, HI, IL, IN, KS, MI, MO, NC, ND, NM, NY, OH, OR, PA, SC, TN, TX, VA, WA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1467-2021, Z-1466-2021

Terminated Class II Medical devices

Recall started
2 October 2019
Terminated
29 July 2020
Reason
The devices are not labelled correctly. End users impacted by this issue may experience a procedural delay.
Distribution
The products were distributed to the following US states: LA, MA, OR, VA, and WA.
Initiated
Voluntary: Firm initiated
Recall number
Z-0411-2020

Terminated Class II Medical devices

Recall started
18 September 2019
Terminated
24 September 2020
Reason
Snap lock connectors provided within implantable port kits may not meet dimensional specifications, and the catheter cannot be inserted into the snap lock connector prior to connection to the port chamber, resulting in a delay to the implantation procedure.
Distribution
Worldwide distribution - US Nationwide in the state of CA, CT, FL, GA, IA, IN, KS, KY, MI, MO, MS, MT, NE, NJ, NY, OH, OK, OR, PA, TN, TX, WA, WI and country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0502-2020, Z-0504-2020, Z-0501-2020, Z-0505-2020, Z-0503-2020

Terminated Class II Medical devices

Recall started
17 April 2019
Terminated
9 June 2020
Reason
Updated Warning Statements in the Operator's Manual/Directions for Use and Software Updates to reduce the risk of potential patient harm due to a delay in performing a procedure
Distribution
Worldwide distribution - US Nationwide distribution and countries of AE AT AU BE CA CH CL CO CZ DE DK DZ EG ES FR GB GE GR HK IE IL IN IQ IT LB LT MC MT MX NL NZ PL PT SG TH TR TW VN ZA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1700-2019, Z-1702-2019, Z-1704-2019, Z-1701-2019, Z-1703-2019

Terminated Class II Medical devices

Recall started
16 October 2018
Terminated
26 June 2020
Reason
Specific lots of Xcela Power Injectable and BioFlo PICCs are labelled with incorrect expiration dates. The labelled expiration date extends the shelf life of the product beyond the date supported by validation testing. Although the product under recall has not yet reached its validated expiry date, removal of the affected product is warranted to prevent use beyond the validated expiry date.
Distribution
Distributed to accounts in Florida. Foreign distribution to Great Britain.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0595-2019, Z-0596-2019

Terminated Class II Medical devices

Recall started
24 July 2018
Terminated
17 May 2019
Reason
BioFlo Ports was partially manufactured with the incorrect sterile port assembly. The actual sterile port assembly used was, 8F SL Xcela Plus Titanium Valved Non-Filled, when it should have been, 8F SL BioFlo Plastic Valved Non-Filled
Distribution
US Nationwide in the state of IN.
Initiated
Voluntary: Firm initiated
Recall number
Z-0076-2019

Terminated Class II Medical devices

Recall started
10 May 2018
Terminated
13 May 2020
Reason
A component of the kits might contain unsafe levels of bacterial endotoxins (pyrogens).
Distribution
The products were distributed to the following US states: AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, WA, WI, and WV. The products were distributed to the following foreign countries: Canada, China, Ireland, Spain.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2218-2018, Z-2207-2018, Z-2205-2018, Z-2199-2018, Z-2200-2018, Z-2210-2018, Z-2222-2018, Z-2219-2018, Z-2212-2018, Z-2208-2018, Z-2220-2018, Z-2191-2018 and 26 more

Terminated Class II Medical devices

Recall started
18 January 2018
Terminated
21 September 2018
Reason
NAMIC Fluid Management Convenience Kits contains a Fluid Delivery Set that was not assembled in accordance with specification, and prevents the device from being used, resulting in a minor delay in procedure.
Distribution
Recall conducted to end user level. Recall Notifications were delivered by Fed Express.
Initiated
Voluntary: Firm initiated
Recall number
Z-1390-2018

Terminated Class II Medical devices

Recall started
17 October 2017
Terminated
14 June 2022
Reason
Mislabeled: The product is labeled as 5F (55cm; Maximum Flow Rate 3.5 mL/Sec) and the product is actually 4F (55cm; Maximum Flow Rate 3.5 mL/Sec).
Distribution
Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-2617-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.